| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $186K | -21.0% | -23.4% |
| SG&A Expense | $210K | -27.0% | -25.5% |
| Pre-tax Income | $7.0M | +1909.8% | +871.2% |
| Net Income | $6.9M | +1872.5% | +855.4% |
| EPS (Basic) | $0.31 | +1650.0% | +875.0% |
| EPS (Diluted) | $0.31 | +1650.0% | +875.0% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $10.7M | +83.6% | +241.9% |
| Total Assets | $10.9M | +73.8% | +140.9% |
| Current Liabilities | $1.3M | -58.8% | -67.3% |
| Total Liabilities | $1.4M | -57.7% | -64.8% |
| Stockholders' Equity | $9.5M | +215.6% | +1431.7% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.1M | -84.1% | — |
| Capital Expenditures | $15K | +728.7% | — |
| Investing Cash Flow | -$15K | -728.7% | — |
| Financing Cash Flow | $763K | +70.5% | — |
| Free Cash Flow | -$1.1M | -86.0% | — |